市場調査レポート

商品コード

1801167

顔用注射剤の市場規模、シェア、動向、予測：製品タイプ、用途別、エンドユーザー別、地域別、2025～2033年

Facial Injectables Market Size, Share, Trends and Forecast by Product Type, Application Type, Application, End User, and Region, 2025-2033

出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 447,600円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペースト、印刷はできません。

PDF & Excel (5 User License)

USD 3,999 596,850円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストはできませんが、印刷は5部まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 746,100円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストは可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.25円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

顔用注射剤の世界市場規模は2024年に91億7,000万米ドルとなりました。今後、IMARC Groupは、同市場が2033年には188億米ドルに達し、2025年から2033年にかけて7.89%のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年の市場シェアは39.0%です。市場を牽引しているのは、若々しい外見を維持するために効果的なアンチエイジングソリューションを求める高齢化人口の増加です。ボトックスや皮膚充填剤のような非侵襲的治療に対する需要の高まりは、ダウンタイムを最小限に抑えた迅速で低リスクの治療を好む個人を惹きつけています。さらに、有名人の推薦やソーシャルメディアの影響力により、美容的な強化が大幅に正常化され、より多くの人々がこれらの施術を選ぶようになっています。これらの要因が相まって、顔用注射剤の市場シェアに拍車がかかり、修正治療と予防治療の両方で好まれる選択肢となっています。

顔用注射剤市場の主な成長促進要因は、非外科的美容治療に対する需要の増加です。ボトックス、ダーマフィラー、その他の注射治療などの非外科的美容医療は、従来の美容整形手術よりも即効性があり、ダウンタイムが短く、合併症が少ないため、顧客に選ばれています。この動向は、美的改善に関する意識の高まり、ソーシャルメディア文化、あらゆる世代が若い容姿を求めていることなども背景にあります。また、注入剤製品の改良と、より安全で長時間作用する製品の入手が可能になったことで、より幅広い顧客層が注入剤に引き寄せられ、低侵襲治療が主要な顔用注射剤市場動向へと変化しています。

米国は顔用注射剤市場において支配的な役割を担っており、高い消費者意識、高度なヘルスケアインフラ、旺盛な美容需要に支えられており、市場シェアは88.20%です。熟練した皮膚科医や美容外科医が多く、ボトックスやダーマルフィラーのような低侵襲施術の主要拠点となっています。2023年だけでも、約948万件の神経調節剤注射と529万件のヒアルロン酸フィラー施術が行われ、それぞれ前年比9%と8%の伸びを示しました。ソーシャルメディアの影響力、有名人の動向、若々しい外見への注目の高まりが需要をさらに促進しています。FDAの支持的な規制、可処分所得の増加、アンチエイジングソリューションを求める高齢化社会は、米国市場の主導的地位を強化しています。

顔用注射剤市場動向：

高齢化人口の増加：

世界人口の高齢化に伴い、顔用注射剤の需要が高まっています。美容医療は必要不可欠であるが、加齢にはしわ、小じわ、たるみなど様々な目に見えるサインが伴う。そのため、若々しさを保つために美容治療を選ぶ人が後を絶ちません。顔用注射剤は、ダウンタイムがゼロで、外科的な処置を必要としないため、侵襲的な治療を受けることなく、自己若返りについて問い合わせをする幅広い聴衆を奨励しています。さらに、先進諸国では年齢層が拡大しており、人々は自分の外見により気を遣うようになっています。それゆえ、彼らは最高の外見と感触を得るために美容治療を求めることを厭わず、顔用注射剤市場の見通しに影響を与えています。世界保健機関（WHO）によると、2020年には60歳以上の世界人口が5歳未満児を上回る。高齢化率は2015年の12%から2050年には22%に倍増すると予想されています。

非侵襲的治療への需要の高まり

利便性、ダウンタイムの少なさ、リスクの減少、副作用の少なさから、非侵襲的な顔面形成術を選ぶ人が増えています。例えば、皮膚充填剤やボツリヌス毒素注射は、しわ、容積減少、顔の非対称性など、多くの一般的な審美的問題に迅速かつ効率的な解決策を提供する注射剤です。さらに、多忙な生活や、多くの施術を効率的で危険の少ないものにする技術の進歩が、新世代の非侵襲的顔面治療に影響を与え、顔用注射剤市場価値を高めています。米国形成外科学会（ASPS）のデータによると、2022年に米国で実施された外科的および低侵襲的な美容・再建治療は合計2,620万件に上ります。また、美容外科手術の19％が2019年以降に手術され、顔用注射剤市場の需要を高めていることも明らかになりました。

有名人の推薦とソーシャルメディアの影響力

美容の基準や消費者の嗜好は、有名人の推薦やソーシャルメディアのパーソナリティの影響を受けており、これが顔用注射剤市場の成長を促進しています。有名人が自分の顔の整形手術についてオープンに話したり、様々なソーシャルメディアサイトに投稿したりすると、そのフォロワーは顔用注射剤の使用を検討する可能性が高くなります。例えば、米国顔面形成外科学会（AAFPRS）の調査によると、顔面形成外科医は2019年以降、フェイスリフトが90％増加したと報告しています。昨年、フェイスリフトは女性のための主要な外科手術であり、86％の外科医が行っていました。鼻の整形または隆鼻術は2位で、外科医は79％に施行しており、眼瞼形成術またはアイリフトは73％でした。男女ともに、鼻形成術が83％、眼瞼形成術が49％、フェイスリフトと部分的フェイスリフトが48％です。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ

第11章 SWOT分析

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

第14章価格分析

第15章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Allergan Plc
- Anika Therapeutics Inc.
- Bloomage BioTechnology
- Johnson & Johnson
- Galderma Pharma S.A.
- Integra LifeSciences
- Ipsen（Mayroy SA）
- Medytox Inc.
- Merz Holding GmbH & Co. KG
- Prollenium Medical Technologies Inc.
- Sanofi
- SciVision Biotech Inc.
- Sinclair Pharma（Huadong Medicine Co. Ltd.）
- Suneva Medical Inc.
- Bausch Health Companies Inc.

図表

List of Figures

Figure 1: Global: Facial Injectables Market: Major Drivers and Challenges
Figure 2: Global: Facial Injectables Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Facial Injectables Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Facial Injectables Market: Breakup by Product Type (in %), 2024
Figure 5: Global: Facial Injectables Market: Breakup by Application Type (in %), 2024
Figure 6: Global: Facial Injectables Market: Breakup by Application (in %), 2024
Figure 7: Global: Facial Injectables Market: Breakup by End User (in %), 2024
Figure 8: Global: Facial Injectables Market: Breakup by Region (in %), 2024
Figure 9: Global: Facial Injectables (Collagen) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Facial Injectables (Collagen) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Facial Injectables (Hyaluronic Acid) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Facial Injectables (Hyaluronic Acid) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Facial Injectables (Botulinum Toxin Type A) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Facial Injectables (Botulinum Toxin Type A) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Facial Injectables (Calcium Hydroxylapatite) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Facial Injectables (Calcium Hydroxylapatite) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Facial Injectables (Polymethylmethacrylate Beads) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Facial Injectables (Polymethylmethacrylate Beads) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Facial Injectables (Poly-L-Lactic Acid) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Facial Injectables (Poly-L-Lactic Acid) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Facial Injectables (Other Product Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Facial Injectables (Other Product Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Facial Injectables (Aesthetics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Facial Injectables (Aesthetics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Facial Injectables (Therapeutics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Facial Injectables (Therapeutics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Facial Injectables (Facial Line Correction) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Facial Injectables (Facial Line Correction) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Facial Injectables (Lip Augmentation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Facial Injectables (Lip Augmentation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Facial Injectables (Face Lift) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Facial Injectables (Face Lift) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Facial Injectables (Acne Scar Treatment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Facial Injectables (Acne Scar Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Facial Injectables (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Facial Injectables (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Facial Injectables (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Facial Injectables (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Facial Injectables (Dermatology Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Facial Injectables (Dermatology Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Global: Facial Injectables (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Global: Facial Injectables (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: North America: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: North America: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: United States: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: United States: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Canada: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Canada: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Asia-Pacific: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Asia-Pacific: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: China: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: China: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Japan: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Japan: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: India: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: India: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: South Korea: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: South Korea: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Australia: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Australia: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Indonesia: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Indonesia: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Others: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Others: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Europe: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Europe: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Germany: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Germany: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: France: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: France: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: United Kingdom: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: United Kingdom: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Italy: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Italy: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Spain: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Spain: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Russia: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Russia: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Others: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Others: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Latin America: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Latin America: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Brazil: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Brazil: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Mexico: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Mexico: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Others: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Others: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Middle East and Africa: Facial Injectables Market: Sales Value (in Million USD), 2019 & 2024
Figure 90: Middle East and Africa: Facial Injectables Market: Breakup by Country (in %), 2024
Figure 91: Middle East and Africa: Facial Injectables Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 92: Global: Facial Injectables Industry: SWOT Analysis
Figure 93: Global: Facial Injectables Industry: Value Chain Analysis
Figure 94: Global: Facial Injectables Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Facial Injectables Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Facial Injectables Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
Table 3: Global: Facial Injectables Market Forecast: Breakup by Application Type (in Million USD), 2025-2033
Table 4: Global: Facial Injectables Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Facial Injectables Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 6: Global: Facial Injectables Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Facial Injectables Market Structure
Table 8: Global: Facial Injectables Market: Key Players

Product Code: SR112025A2814

The global facial injectables market size was valued at USD 9.17 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 18.80 Billion by 2033, exhibiting a CAGR of 7.89% from 2025-2033. North America currently dominates the market, holding a market share of 39.0% in 2024. The market is driven by a growing aging population seeking effective anti-aging solutions to maintain youthful appearances. Rising demand for non-invasive procedures like Botox and dermal fillers attracts individuals preferring quick, low-risk treatments with minimal downtime. Additionally, celebrity endorsements and social media influence have significantly normalized aesthetic enhancements, encouraging more people to opt for these procedures. Combined, these factors are fueling facial injectables market share, making them a preferred choice for both corrective and preventive cosmetic treatments.

The key growth driver of the facial injectables market is increasing demand for non-surgical aesthetic treatments. Customers are opting for non-surgical aesthetics such as Botox, dermal fillers, and other injectable treatments because of their fast effects, less downtime, and lower complications than conventional cosmetic surgery. The trend is also driven by rising awareness regarding aesthetic improvements, social media culture, and seeking young looks among all generations. Also, improvements in injectable products and availability of safer, longer-acting products are drawing a wider customer base towards it, thus converting minimally invasive treatments into a leading facial injectables market trend.

The U.S. plays a dominant role in the facial injectables market, supported by high consumer awareness, advanced healthcare infrastructure, and strong demand for aesthetic enhancements with a market share of 88.20%. With a large base of skilled dermatologists and cosmetic surgeons, the country is a leading hub for minimally invasive procedures like Botox and dermal fillers. In 2023 alone, approximately 9.48 million neuromodulator injections and 5.29 million hyaluronic acid filler procedures were performed, reflecting year-over-year growth of 9% and 8%, respectively. Social media influence, celebrity trends, and a growing focus on youthful appearances further drive demand. Supportive FDA regulations, rising disposable incomes, and an aging population seeking anti-aging solutions strengthen the U.S. market's leading position.

Facial Injectables Market Trends:

Increasing Aging Population:

As the global population is aging the demand for facial injectables is rising. While they are essential, aging comes with various visible signs like wrinkles, fine lines, and sagging skin. Thus, individuals always opt for aesthetic treatments to keep a youthful appearance. Due to the zero downtime and non-surgical procedure, facial injectables encourage a wide audience inquiring about self-rejuvenation without undergoing invasive treatments. Furthermore, the age sector in developed countries is expanding, and people now care more about their appearance. Hence, they are willing to seek aesthetic treatments to look and feel their best, influencing the facial injectables market outlook. In 2020, the global population aged 60 years and above exceeded the under-five children, according to the World Health Organization. The aging population is expected to double globally from 12% in 2015 to 22% in 2050.

Rising Demand for Non-Invasive Procedures

Individuals are opting for non-invasive facial plastic procedures owing to their convenience, minimal downtime decreased risk, and fewer side effects. For example, dermal fillers and botulinum toxin injections, are injectables that provide quick and efficient solutions to numerous common aesthetic problems like wrinkles, volume depletion, and facial asymmetry. Moreover, busy lives, and technological advances that make many procedures efficient and less dangerous, influence the new generation of non-invasive face treatments, which is increasing the facial injectables market value. Data from the American Society of Plastic Surgeons (ASPS) reveals that a total of 26.2 million surgical and minimally invasive cosmetic and reconstructive treatments were performed in the United States in 2022. It also reveals that 19% of cosmetic surgeries surged since 2019, increasing the facial injectables market demand.

Celebrity Endorsements and Social Media Influence

Beauty standards and consumer preferences are influenced by celebrity endorsements and social media personalities which is driving the facial injectables market growth. When celebrities openly discuss their facial plastic surgeries or post about them on various social media sites, their followers are more likely to consider using facial injectables. For instance, according to the survey by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), facial plastic surgeons have reported a 90% rise in facelifts since 2019. Last year, facelifts were the leading surgical procedure for females, with 86% of surgeons performing them. Noses jobs or rhinoplasty come second, with surgeons performing them on 79%, while blepharoplasty or eye lift stood at 73%. For both genders, the top three surgical procedures are rhinoplasty accounting for 83%, blepharoplasties at 49%, and facelifts and partial facelifting at 48%.

Facial Injectables Industry Segmentation:

Analysis by Product Type:

Collagen
Hyaluronic Acid (HA)
Botulinum Toxin Type A
Calcium Hydroxylapatite (CaHA)
Polymethylmethacrylate Beads (PMMA Microspheres)
Poly-L-Lactic Acid (PLLA)
Others

Based on the facial injectables market forecast, the botulinum toxin type A dominates the facial injectables market with a market share of 54.8% due to its proven effectiveness, quick results, and wide range of cosmetic and therapeutic applications. It is highly preferred for reducing fine lines, wrinkles, and other signs of aging, making it a go-to choice for minimally invasive facial rejuvenation. Its non-surgical nature, minimal downtime, and relatively low risk profile attract a broad demographic of patients seeking aesthetic enhancements. Additionally, its temporary but noticeable results encourage repeat procedures, driving sustained demand. Growing awareness, expanding indications, and the increasing acceptance of preventive cosmetic treatments among younger populations further strengthen its market dominance. Continuous advancements in formulation and delivery methods also enhance its appeal, supporting its leading position in the segment.

Analysis by Application Type:

Aesthetics
Therapeutics

Aesthetics account for the majority of shares of 35.0% driven by the rising demand for minimally invasive cosmetic enhancements aimed at improving appearance and boosting confidence. Increasing awareness of aesthetic procedures, fueled by social media influence, celebrity trends, and changing beauty standards, has significantly expanded the customer base. Patients prefer injectables for their quick results, minimal downtime, and reduced risks compared to surgical interventions. Additionally, the growing popularity of preventive treatments among younger individuals and anti-aging solutions among older populations further drives demand. Continuous innovations in product formulations, offering longer-lasting and more natural results, also contribute to the dominance of the aesthetics segment, making it the largest and most rapidly growing application area in this market.

Analysis by Application:

Facial Line Correction
Lip Augmentation
Face Lift
Acne Scar Treatment
Others

According to the facial injectables market analysis, the facial line correction is a leading application of injectables, primarily targeting wrinkles, fine lines, and folds caused by aging or facial expressions. Botulinum toxin and dermal fillers are commonly used to smoothen skin, restore youthful contours, and enhance facial aesthetics with minimally invasive, quick, and effective treatments.

Additionally, the lip augmentation uses dermal fillers to enhance lip volume, shape, and definition. It is popular among younger patients seeking fuller lips and older individuals addressing age-related thinning. Minimally invasive techniques and customizable results make it a sought-after procedure, boosting demand for injectables in aesthetic treatments.

Moreover, the non-surgical facelifts with injectables help restore facial volume, reduce sagging, and enhance contours without invasive surgery. Dermal fillers and neuromodulators are combined to achieve natural-looking rejuvenation. The quick recovery and lower risk compared to surgical facelifts make this approach increasingly attractive to patients.

Besides this, the injectables play a vital role in improving acne scars by filling depressions and stimulating collagen production. Dermal fillers provide immediate volume restoration, while some injectables promote long-term skin healing. This minimally invasive option appeals to patients seeking smoother skin without downtime, driving growth in aesthetic dermatology.

Besides this, the other applications include chin augmentation, tear trough correction, and non-surgical nose reshaping. These procedures address specific facial concerns, improving symmetry and enhancing overall facial aesthetics. The versatility of injectables, combined with personalized treatment plans, expands their use across varied cosmetic and reconstructive applications, contributing to overall market growth.

Analysis by End User:

Hospitals
Dermatology Clinics
Others

Hospitals represent significant growth with a market share of 45% due to their ability to offer comprehensive care, advanced facilities, and high safety standards. Patients often prefer hospitals for injectable treatments due to the availability of experienced specialists, access to emergency care, and adherence to stringent regulatory protocols. Hospitals also cater to both cosmetic and therapeutic applications of injectables, attracting a diverse patient base. The growing number of hospital-based aesthetic clinics, combined with the rising demand for minimally invasive procedures, boosts their role in market expansion. Additionally, hospitals often serve as training and research centers, fostering innovation and ensuring the availability of the latest injectable products and techniques, further driving their contribution to market growth.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America leads the facial injectables market with a market share of 39.0% driven by high consumer awareness, strong demand for aesthetic enhancements, and advanced healthcare infrastructure. The region benefits from a well-established network of skilled dermatologists and cosmetic practitioners who offer a wide range of minimally invasive procedures. Increasing social media influence, changing beauty standards, and the growing acceptance of cosmetic treatments across various age groups fuel market growth. Additionally, the presence of innovative, regulatory-approved injectable products ensures access to safe and effective solutions. Rising disposable incomes, a large aging population seeking anti-aging treatments, and the popularity of preventive aesthetics among younger consumers further support North America's dominance in this market. Continuous technological advancements and frequent product innovations also play a key role.

Key Regional Takeaways:

United States Facial Injectables Market Analysis

The United States facial injectables market is primarily driven by increasing consumer demand for non-invasive aesthetic treatments. In line with this, individuals increasingly seeking quicker and safer methods to enhance their appearance are impelling the market. The continual advancements in injectable formulations, which provide longer-lasting results, are further propelling the market growth. Similarly, heightened awareness about facial aging and available treatments is encouraging more patients to opt for injectables. The expanding aging population in the U.S. is creating a larger customer base, fueling market development. According to Census.gov, in 2024, the U.S. had 61.2 million individuals aged 65 and older, marking a 13% rise from 54.2 million in 2020, while the number of children (ages 0 to 17) decreased, reflecting the national aging trend. Furthermore, the growing influence of social media and celebrity endorsements is significantly increasing interest in aesthetic procedures, strengthening market demand. Furthermore, favorable reimbursement policies in certain states are also contributing to the enhanced market's appeal. Moreover, ongoing technological innovations in injectables, along with improved safety profiles, continue to enhance consumer confidence, accelerating higher adoption rates.

Europe Facial Injectables Market Analysis

The market in Europe is witnessing growth propelled by the increasing consumer preference for minimally invasive aesthetic procedures, offering quick recovery and natural results. In accordance with this, the growing focus on anti-aging treatments, fueled by the rising elderly population, is propelling market expansion. As such, Cambridge-based biotech Clock.bio raised USD 5.3 Million in a seed round led by LocalGlobe, focusing on reversing cellular aging using human pluripotent stem cells and CRISPR, aiming to develop anti-aging treatments. Similarly, the heightened influence of social media and celebrity endorsements is further augmenting awareness and demand for these treatments across the region. Additionally, the emerging trend of personalized skincare, with customized injectables tailored to individual skin types, is attracting more consumers to the market. An industry report highlights that in Europe, especially the UK, 60% of consumers prioritize skincare products that are vegan, organic, and ethically sourced, underscoring the rising demand for personalized products that blend effectiveness with ethical principles. The increased affordability of treatments, driven by competitive pricing and innovative financing options, is also contributing to the market's growth. Apart from this, rising healthcare awareness and the expanding focus on self-care are encouraging individuals to invest in facial injectables, further strengthening market momentum.

Asia Pacific Facial Injectables Market Analysis

The Asia Pacific injectables market for the face is mostly fueled by rising disposable incomes and shifting beauty ideals, resulting in greater utilization of aesthetic treatments. Likewise, the expansion of medical tourism in countries such as Thailand and South Korea is further boosting market demand. Based on the Ministry of Health and Welfare's data, South Korea's medical tourism sector saw high growth in 2024, as the number of overseas patients almost doubled to 1.17 million from 605,768 in 2023. Growth in dermatology clinics and medical spas is popularizing injectables in the marketplace. In addition, increased social media and celebrity culture influence is also increasing awareness and expanding market size. Also, the increasing demand for non-surgical over conventional surgeries is favoring market demand since patients are opting for quicker results and less time spent in recovery. Further, the regional competitive environment is favoring the establishment of innovative injectable products, hence opening up profitable market opportunities.

Latin America Facial Injectables Market Analysis

In Latin America, the market for facial injectables is increasing because of the expanding middle class who are looking for aesthetic procedures. The International Society of Aesthetic Plastic Surgery (ISAPS) 2021 survey listed Brazil, Mexico, Argentina, and Colombia in the top 10 nations for aesthetic procedure, with Brazil being ranked second globally for combined surgical and nonsurgical procedures. Apart from this, the growth of influencer culture is broadening awareness and defining beauty trends, and it is urging more people to seek cosmetic procedures. The constant development of product formulas, providing longer-lasting effects with minimal side effects, are also helping boost consumer confidence in the market. In addition to this, the rising popularity of non-invasive beauty treatments among both men and women is backing the region's rising market for facial injectables.

Middle East and Africa Facial Injectables Market Analysis

The Middle East and Africa market is significantly expanding due to increasing disposable incomes, enabling consumers to prioritize aesthetic procedures. Furthermore, the growing influence of social media driving demand for cosmetic enhancements is impelling the market. The rise in medical tourism within the region is attracting international patients, further stimulating the market appeal. Industry analysis highlighted that Dubai is emerging as a prominent medical tourism hub. In 2023, the city welcomed over 691,000 health tourists, 58% of whom were women, primarily seeking gynecology and cosmetic surgery. These visitors collectively spent over AED 1 Billion (USD 280 Million) on treatments. Besides this, continual advancements in healthcare infrastructure are expanding access to modern injectable technologies, improving treatment options, and market accessibility.

Competitive Landscape:

The competitive environment is extremely dynamic and driven by innovation, with many players competing on enlarging the product portfolio and enhancing treatment effectiveness. Competitors compete on product safety, effectiveness, long-term results, and ease of use, leading to relentless investment in research and development. Strategic partnerships, mergers, and product introductions are prevalent to consolidate market positions and enhance offerings. In addition, the growth of minimally invasive treatments has contributed to more competition among manufacturers in creating more sophisticated injectables with longer durations and fewer side effects. The market also experiences heightened focus on patient education, customized treatment methods, and practitioner education, which further increases competition. In general, the market is influenced by technological advancements, regulatory clearances, and the increasing global demand for aesthetic treatments.

The report provides a comprehensive analysis of the competitive landscape in the facial injectables market with detailed profiles of all major companies, including:

Allergan Plc
Anika Therapeutics Inc.
Bloomage BioTechnology
Johnson & Johnson
Galderma Pharma S.A.
Integra LifeSciences
Ipsen (Mayroy SA)
Medytox Inc.
Merz Holding GmbH & Co. KG
Prollenium Medical Technologies Inc.
Sanofi
SciVision Biotech Inc.
Sinclair Pharma (Huadong Medicine Co. Ltd.)
Suneva Medical Inc.
Bausch Health Companies Inc.

Key Questions Answered in This Report

1.How big is the facial injectables market?
2.What is the future outlook of facial injectables market?
3.What are the key factors driving the facial injectables market?
4.Which product type accounts for the largest facial injectables market share?
5.Which application type accounts for the largest facial injectables market share?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Facial Injectables Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Collagen
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Hyaluronic Acid (HA)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Botulinum Toxin Type A
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Calcium Hydroxylapatite (CaHA)
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Polymethylmethacrylate Beads (PMMA Microspheres)
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
6.6 Poly-L-Lactic Acid (PLLA)
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
6.7 Others
- 6.7.1 Market Trends
- 6.7.2 Market Forecast

7 Market Breakup by Application Type

7.1 Aesthetics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Therapeutics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Application

8.1 Facial Line Correction
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Lip Augmentation
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Face Lift
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Acne Scar Treatment
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by End User

9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Dermatology Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Allergan Plc
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Anika Therapeutics Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 SWOT Analysis
- 15.3.3 Bloomage BioTechnology
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Johnson & Johnson
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Galderma Pharma S.A.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 SWOT Analysis
- 15.3.6 Integra LifeSciences
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Ipsen (Mayroy SA)
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Medytox Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
- 15.3.9 Merz Holding GmbH & Co. KG
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
- 15.3.10 Prollenium Medical Technologies Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
- 15.3.11 Sanofi
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis
- 15.3.12 SciVision Biotech Inc.
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
- 15.3.13 Sinclair Pharma (Huadong Medicine Co. Ltd.)
  - 15.3.13.1 Company Overview
  - 15.3.13.2 Product Portfolio
- 15.3.14 Suneva Medical Inc.
  - 15.3.14.1 Company Overview
  - 15.3.14.2 Product Portfolio
- 15.3.15 Bausch Health Companies Inc.
  - 15.3.15.1 Company Overview
  - 15.3.15.2 Product Portfolio
  - 15.3.15.3 Financials
  - 15.3.15.4 SWOT Analysis

顔用注射剤の市場規模、シェア、動向、予測：製品タイプ、用途別、エンドユーザー別、地域別、2025～2033年

Facial Injectables Market Size, Share, Trends and Forecast by Product Type, Application Type, Application, End User, and Region, 2025-2033

顔用注射剤市場動向：

高齢化人口の増加：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の顔用注射剤市場

第6章 市場内訳：製品タイプ別

第7章 市場内訳：用途別

第8章 市場内訳：用途別

第9章 市場内訳：エンドユーザー別

第10章 市場内訳：地域別

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢